El grupo Neurodegeneración corneal del IDIS descubre biomarcadores en lágrima claves para detectar precozmente el queratocono en hijos de pacientes afectados

El estudio realizado por la Dra. Isabel Lema y su equipo ha sido publicado por IOVS – Investigative Ophtalmology & Visual Science, principal revista en oftalmología

La élite de la investigación sobre enfermedades renales crónicas se reúne este fin de semana en Portonovo

El grupo de investigación NefroCHUS del IDIS, organiza este año la II Jornada de Investigación Traslacional RICORS2040-RENAL

Cáncer, enfermedad de Fabry, alzhéimer o autismo entre los trabajos premiados en Biointegrasaúde 2025

El IDIS se hizo con cuatro de los seis trabajos premiados, elegidos entre 67 comunicaciones orales y 88 pósteres

News

Calendar

Load More

COMMON SUPPORT PLATFORMS

The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.

CALLS

All updated information on public and private competitive calls. The most convenient and safest way to send your requests.

CAREERS

Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.

Research Areas

ONCOLOGY

Improvement of treatments: personalised therapy and reduction of side effects.

GENETICS AND SYSTEMS BIOLOGY

Identification of genetic biomarkers of disease susceptibility and prognosis

ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO

The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.

NEUROSCIENCES

Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.

CARDIOVASCULAR

The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.

PLATFORMS AND METODOLOGY

The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.

Privacy overview

This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.